Posted April 27, 2018
The U.S. Food and Drug Administration today approved a supplemental New Animal Drug Application (NADA) submitted by AquaBounty Technologies, Inc. The supplemental NADA requested FDA approval to raise AquAdvantage Salmon — a product under an application previously approved in 2015 — at a land-based contained facility near Albany, Indiana. Read more.